Method, composition and kit to predict the responsiveness of a patient with solid cancer to an anticancer agent and method for screening patient specific therapeutic agent for solid cancer treatment

摘要

Method, composition and kit to predict the responsiveness of a patient with solid cancer to an anticancer agent and method for screening patient specific therapeutic agent for solid cancer treatment, refers to a marker to predict the responsiveness of a cancer patient with cancer Solid to an anticancer agent. The marker, according to the present invention, can be advantageously used to select a subgroup, which effectively responds to an anticancer therapy with a specific anticancer agent, between patients with solid cancer, or to determine a treatment method for patients With solid cancer.